Advances in the management of myeloma bone disease

Author： Shipman Claire M Oyajobi Babatunde O Mundy Gregory R

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.16, 2005-12, pp. : 2781-2791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dickkopf-1: a suitable target for the management of myeloma bone disease

By Gavriatopoulou Maria Dimopoulos Meletios-Athanasios Christoulas Dimitrios Migkou Magdalini Iakovaki Marina Gkotzamanidou Maria Terpos Evangelos

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 839-848

Informa Healthcare

Access to resources Recommend Favorite

Role of Bone Marrow Transplantation in the Disease Pathway of Myeloma

By Harousseau Jean-Luc Moreau Philippe

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 2, 2007-02 ,pp. : 163-169

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 701-711

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Pharmacological Management of Huntington's Disease

By Frank Samuel

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 561-571

Adis International

Access to resources Recommend Favorite

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

Current Cancer Drug Targets, Vol. 9, Iss. 7, 2009-01 ,pp. : 854-870

Bentham Science Publishers

Access to resources Recommend Favorite